SCHEMBL23819051

SCHEMBL23819051

CCC(=O)O[C@@H](c1ccc2c(N)ncnn12)[C@H](OC(=O)CC)C(C#N)(COCN[C@@H](C)C(=O)OC(C)C)OC

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23818879 0.96 RIPK1 (0.30) —
SCHEMBL23819007 0.91 RIPK1 (0.30) —
SCHEMBL23818654 0.91 RIPK1 (0.30) —
SCHEMBL23819336 0.90 — —
SCHEMBL23819073 0.89 — —
SCHEMBL26332823 0.88 — —
SCHEMBL26340446 0.88 RIPK1 (0.31) —
SCHEMBL27442612 0.87 — —
SCHEMBL23819173 0.87 RIPK1 (0.31) —
SCHEMBL26345159 0.87 RIPK1 (0.31) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210284670-A1 ANTIVIRAL COMPOUNDS GILEAD SCIENCES, INC. 2021-09-16 — — US disclosed
Send feedback